# HFSG — Final Acceptance Summary (Phase 1)

**Stage:** Final Acceptance preparation — the Project Owner reviews this and the supporting release material before issuing Final Acceptance. **Final Acceptance is issued by the Project Owner; it is declared by him, not by this package.**
**Date:** 2026-09-05
**Reference decisions:** HFSG-PH1-DEV-001 (Scale Qualification Deferral)

> **Phase 1 data status:** These are SYNTHETIC, SCENARIO-DRIVEN simulated data. They MUST NOT be represented or used as clinically validated, real-world-equivalent, or patient-identifiable clinical data.

---

## 1. What was delivered in Phase 1

1. **Model B core engine** — compartmental hospital-flow simulation (ED, Specialty, General Ward, ICU), with the authority chain `requested_raw_flow → constrained_raw_flow → realized_integer_flow`; the realized integer flow is authoritative for patient events and operational aggregate stocks.
2. **Integer Flow Allocation** — Largest Remainder Method + seeded deterministic tie-break.
3. **Scenario framework** — Standard-8 (S1–S8) + CUSTOM on the same Core Engine; configuration-driven, no scenario-specific model logic.
4. **Patient layer** — Initial Patient Population (115 per run), Patient Generator, Patient Event Generator (unique patient/event ids, chronological events, one active location per patient).
5. **Reconciliation & validation** — aggregate↔patient reconciliation, event↔quota reconciliation, mass balance, capacity/source/stock invariants, uniqueness, temporal consistency; required checks all PASS.
6. **Deterministic seeding** — `master_seed = 20260805` → deterministic child seed per (scenario, run); recorded in every run.
7. **Output pipeline** — all 8 approved outputs (patients, patient events, aggregate timeseries, simulation summary, scenario comparison, dataset manifest, validation report, used configuration), scenario_id-partitioned ZSTD Parquet, bounded memory.
8. **Released dataset** — `HFSG-DS-STD8-2026-20260905-120702` at `data/output/step9`: **109,119 patients / 316,010 events / 58,320 aggregate rows**, 81 runs, S1–S8 + CUSTOM coverage, **VALIDATED** (0 critical failures), **RELEASED**.
9. **Tests** — 177 passing; `compileall` PASS; `git diff --check` clean.
10. **Reproducibility** — seed policy, preserved configuration (config hash `f5e1bc49…8dcd`), checkpoint/resume, 9-run replay sample with 0 failures.

## 2. What was deferred

- **`>= 1,000,000`-patient production Batch — DEFERRED to Phase 2 as Scale Qualification** (HFSG-PH1-DEV-001). Current hardware (3.7 GiB RAM, ~1.3 GiB free disk, 2 CPU cores) cannot feasibly hold/write/validate a 1M dataset. This is **NOT a Phase 1 failure**. Phase 1 approved Acceptance Scale (~100,000 synthetic patients) is satisfied and exceeded (109,119).
- Production scale qualification infrastructure (larger memory/disk, cloud or distributed storage) — Phase 2.

## 3. Remaining known limitations

1. **Scale**: releases are limited to the workstation's memory/disk profile; the full 1M dataset is not buildable on this machine.
2. **Clinical scope**: data are synthetic, scenario-driven and non-identifiable; they carry no clinical validity and must not be used as real-world clinical evidence. There are no clinical variables, diagnoses, medications, labs or vitals (out of Phase 1 scope).
3. **Mortality sparse**: approved-scale runs exhibit 0 deaths (`M_*` flows and `DEATH` events defined but unused in the released dataset).
4. **Scenario run counts**: 9 runs per scenario (81 total) meet the approved ~100K Acceptance Scale; `planned_runs_per_scenario: 120` remains a Phase 2 planning value.
5. **Infrastructure**: no containerization, no distributed execution, no cloud/HIS/EHR integration (out of Phase 1 scope by design).

## 4. Recommendations for Phase 2

These are recommendations only — NOT implemented, NOT a Phase 1 requirement:

1. **Technical — Dockerization / containerization** *[required minimum recommendation]*: package the validated engine as a reproducible Docker image with pinned dependencies (`requirements-lock.txt`) so the pipeline (generate → validate → package) runs identically on any host or CI runner.
2. **Scale Qualification**: execute the `>= 1,000,000`-patient Batch on suitable infrastructure (≥32 GiB RAM, large disk or object storage, multiple cores or distributed workers), reusing the existing checkpoint/resume and chunked-write machinery; re-run the same validation gates at 1M.
3. **Scale storage**: move produced datasets to object storage and increase chunk sizes; consider partitioned multi-process batch scheduling.
4. **Operational tooling**: add CI for the test suite, artifact retention for handover ZIPs, and backup/versioning for released datasets.
5. **Optional product extensions** (only with explicit owner approval and revised scope): clinical variables/diagnoses/medications, EHR/HIS/FHIR interfaces, LLM/ML features.

## 5. Deliverable inventory

Source (commit `a63d298`, clean working tree), released dataset `HFSG-DS-STD8-2026-20260905-120702`, `HFSG_PH1-DEV-001_Scale_Qualification_Deferral.md`, `FINAL_RELEASE_CHECKLIST.md`, `FINAL_DATA_DICTIONARY.md`, `requirements-lock.txt`, `INSTALLATION_AND_REPRODUCTION.md`, `FINAL_VALIDATION_REPORT.md`, `HFSG_Phase1_Release_Closeout.md`, `SHA256SUMS.txt`, `HANDOVER_MANIFEST.json`, and the handover ZIP `HFSG_Phase1_Final_Handover_v1.0.zip`.

**Awaiting Project Owner Final Acceptance decision.**